Efficacy of gemcitabine combined with oxaliplatin, L-asparaginase and dexamethasone in patients with newly-diagnosed extranodal NK/T-cell lymphoma

There is currently no standard first-line regimen for patients with extranodal natural killer (NK)/T-cell lymphoma (ENKTCL). In this study, we investigated the efficacy and toxicity of gemcitabine (GEM) combined with oxaliplatin (L-OHP), L-asparaginase (L-ASP) and dexamethasone (DXM) (GOLD regimen)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GUO, HONG-QIANG, LIU, LEI, WANG, XIN-FENG, LIN, TONG-YU, YAO, SHU-NA, YAO, ZHI-HUA, YANG, SHU-JUN
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2014
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4179794/
https://ncbi.nlm.nih.gov/pubmed/25279218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.368
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge